Literature DB >> 28857242

Down-regulation of the long noncoding RNA-HOX transcript antisense intergenic RNA inhibits the occurrence and progression of glioma.

Bin Yang1, Zhen-Yu Wei2, Bang-Qing Wang1, Hua-Chao Yang3, Jun-Yi Wang3, Xing-Yao Bu1.   

Abstract

This study aims to explore the role of long noncoding RNA (lncRNA)-HOX transcript antisense intergenic RNA (HOTAIR) in the occurrence and progression of glioma. Fresh glioma and normal brain tissues were classified into a glioma group (n = 67) and a normal group (n = 64) respectively. U87 cells were assigned into the blank, sh-NC, and sh-HOTAIR groups. Quantitative real-time polymerase chain reaction (qRT-PCR) was utilized to determine HOTAIR expression. Cell proliferation, cell cycle and cell apoptosis rates were detected by cell counting kit-8 (CCK-8) and flow cytometry (FCM). Scratch test and transwell assay were conducted for cell migration and invasion. Orthotopic glioma tumor model in nude mice was established by inoculating tumor cell suspension. Hematoxylin-Eosin (HE) staining was used to observe the growth and invasion of orthotopic glioma tumors. The expression of HOTAIR and cell viability was found to be lowest in the sh-HOTAIR group among the three groups. The sh-HOTAIR group exhibited a higher apoptotic rate and lower number of cell migration compared with the blank and sh-NC groups. Additionally, the speed of wound healing was slower, the migration distance decreased and the survival time of nude mice was extended in the sh-HOTAIR compared to the other groups. Moreover, the sh-HOTAIR group demonstrated reduced lesion sizes and inflammation, no convulsions or hemiplegia and lesser number of satellite metastases. Our findings support that down-regulation of HOTAIR could inhibit cell proliferation, promote cell apoptosis as well as suppress cell invasion and migration in the progression of glioma.
© 2017 Wiley Periodicals, Inc.

Entities:  

Keywords:  RNA-HOX transcript antisense intergenic RNA; cell apoptosis; cell invasion; cell migration; cell proliferation; glioma cell; long non coding

Mesh:

Substances:

Year:  2017        PMID: 28857242     DOI: 10.1002/jcb.26390

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  4 in total

1.  The evaluation expression of non-coding RNAs in response to HSV-G47∆ oncolytic virus infection in glioblastoma multiforme cancer stem cells.

Authors:  Reza Vazifehmand; Dhuha Saeed Ali; Zulkefley Othman; De-Ming Chau; Johnson Stanslas; Mehdi Shafa; Zamberi Sekawi
Journal:  J Neurovirol       Date:  2022-08-11       Impact factor: 3.739

2.  LncRNA MALAT1 mediates doxorubicin resistance of hepatocellular carcinoma by regulating miR-3129-5p/Nova1 axis.

Authors:  Yongxian Cao; Feng Zhang; Haotian Wang; Chunhua Bi; Jinpeng Cui; Fenghai Liu; Huazheng Pan
Journal:  Mol Cell Biochem       Date:  2020-09-23       Impact factor: 3.396

3.  HOXA10‑AS: A novel oncogenic long non‑coding RNA in glioma.

Authors:  Cheng-Ya Dong; Jiayue Cui; Dian-He Li; Qi Li; Xin-Yu Hong
Journal:  Oncol Rep       Date:  2018-08-21       Impact factor: 3.906

4.  Association between long non-coding RNAs expression and pathogenesis and progression of gliomas.

Authors:  Jie Zhou; Wei Xiang; Shenjie Li; Qi Hu; Tao Peng; Ligang Chen; Yang Ming
Journal:  Oncol Lett       Date:  2018-01-26       Impact factor: 2.967

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.